(Q42848152)
Statements
IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas (English)
C Houillier
X Wang
G Kaloshi
K Mokhtari
R Guillevin
J Laffaire
S Paris
B Boisselier
F Laigle-Donadey
K Hoang-Xuan
M Sanson